Christopher A. Bidwell, JD, Senior Fellow for Nonproliferation Law and Policy, Federation of American Scientists & Mark Jansson, Program Manager, CRDF Global. The U.S. government is making significant investments in bio forensics as a tool for attribution. In order for that investment to pay-off, it must be combined with investments in international collaborations so that the science behind any future attribution claims that may be made are accepted as fact, both in scientific and political terms. To better understand how evidence derived from microbial forensics will be received in international contexts among people with different cultural, professional, and political backgrounds, the Federation of American Read More »
- July 17, 2014 |
Committee on Science Needs Microbial Forensics: Developing an Initial International Roadmap, Board on Life Sciences, Division of Earth and Life Sciences, National Research Council of the National Academies. Today we find ourselves with a complex infrastructure of government agencies, Select Agent registries, regulated research, environmental monitoring in designated cities, federal and state regulations—all resulting from one more or less successful biological attack on the United States. The Amerithrax attack with highly refined material produced by a knowledgeable expert (presumably in a U.S. bioweapons laboratory) resulted in 22 illnesses and 5 deaths. Approximately 4 g of material were used in the Amerithrax attack. Read More »
- July 17, 2014 |
Christina England, Master’s Candidate, Security Policy, University of Maryland School of Public Policy; Intelligence Officer, United States Air Force One of the weakest U.S. bioresponse capabilities is the U.S. medical countermeasure (MCM) enterprise. Few in the fields of public health or biodefense would be surprised to hear that the U.S. is unprepared to respond to a virus for which no medical countermeasures exist. Additionally, bioweapons made resistant to U.S. medical countermeasures would also be catastrophic. Though all seven of the U.S. bioresponse capabilities – detection and diagnosis, attribution, communication, MCM development, MCM dispensing, medical management, and environmental cleanup – are essential in Read More »
- January 16, 2014 |
Op-Ed – Improving Intelligence on Emerging Bioweapons Threats: New Engagements Needed Between Intelligence and Academia
Kathleen M. Vogel, Associate Professor, Department of Science and Technology Studies and the Judith Reppy Institute for Peace and Conflict Studies, Cornell University Since the end of the Cold War and the rise of asymmetric security threats, the U.S intelligence and policy communities have been increasingly concerned about new types of bioweapons attacks that might arise from a spectrum of state and non-state actors. In a 1995 U.S. Senate hearing, CIA official Gordon Oehler lamented that, “the increasingly troubled post–Cold War world has, in a curious way, made us yearn for the dark days of the 1960s and 1970s when we knew Read More »
- January 16, 2013 |
Op-Ed – With the Changing Biological threat…smart international engagement policy would lower cost and increase national security.
David R. Franz, DVM, Ph.D. Former Commander US Army Medical Research Institute of Infectious Diseases “There is no technical solution…”: In 1998, after we understood the enormity of the Soviet offensive program and the potential of the Iraqi one to disrupt, Nobel Laureate Joshua Lederberg said, “There is no technical solution to this problem of biological warfare. It needs an ethical, human and moral solution, if it’s going to happen at all….” Then he paused and said, “But would an ethical or moral solution appeal to a sociopath?” The early days of the biological Nunn-Lugar Cooperative Threat Reduction (CTR) program were similar Read More »
- November 13, 2012 |
Browse by region
Browse By Category
Emergent BioSolutions Inc. today announced that the U.S. Food and Drug Administration has approved Anthrasil [Anthrax Immune Globulin Intravenous (Human)], also known as AIGIV, for treatment of inhalational anthrax in combination with appropriate antibacterial drugs. Achievement of this milestone triggers a $7 million payment to the company under a development contract Read More »
- March 26, 2015
The U.S. Department of Agriculture on Wednesday confirmed the discovery of highly pathogenic avian influenza in a commercial turkey flock in Arkansas, the third-largest U.S. turkey producer and home to Tyson Foods Inc, the nation’s biggest chicken company.
- March 19, 2015
BEIRUT, Lebanon — Anti-government activists in Syria said Tuesday that a chlorine bomb attack by government forces on a northwestern village overnight had killed six people and filled clinics with choking victims.
- March 19, 2015
WHO and the United Nations World Food Programme (WFP) are combining their forces in a new partnership in the Ebola-affected countries of Guinea, Liberia and Sierra Leone. The arrangement combines the logistics strength of WFP with WHO’s public health expertise to help get the current Ebola outbreak down to zero cases Read More »
- March 16, 2015